The Effect of Otilonium Bromide Combined with Helicobacter Pylori Eradication Therapy on Gastrointestinal Hormone Levels in Patients with Functional Dyspepsia
CHEN Rui, WANG Xiaosong, JIANG Bo
Department of Gastroenterology, Suqian Hospital of Jiangsu Province People's Hospital (Suqian First People's Hospital), Suqian Jiangsu 223800
Abstract：【Objective】To explore the effect of otilonium bromide combined with Helicobacter pylori (HP) eradication therapy on gastrointestinal hormone levels in patients with functional dyspepsia (FD).【Methods】A total of 88 FD patients were randomly divided into the observation group and the control group, with 44 cases in each group. Patients in the control group received HP eradication therapy, while those in the observation group received otilonium bromide combined with HP eradication therapy. The clinical efficacy, adverse reactions, gastrointestinal hormone levels, gastric motility indicators, and changes in quality of life before and after treatment were compared between the two groups.【Results】The total effective rate in the observation group was 95.45%, which was higher than that of the control group (79.54%,P<0.05). After treatment, the gastrointestinal hormone levels and gastric motility in both groups significantly improved compared to before treatment, and the improvement in the observation group was better than that in the control group (P<0.05). After treatment, the quality of life scores in both groups increased compared to before treatment, while the score of quality of life in the observation group was higher than that in the control group (P<0.05). There was no significant difference in the total incidence of adverse reactions between the two groups (P>0.05).【Conclusion】Otilonium bromide combined with HP eradication therapy significantly improves gastrointestinal hormone levels, gastric motility indicators, clinical efficacy, and quality of life in FD patients, with a certain level of safety.
[1] WAUTERS L, TALLEY N J, WALKER M M, et al. Novel concepts in the pathophysiology and treatment of functional dyspepsia[J].Gut,2020,69(3):591-600. [2] PESCE M, CARGIOLLI M, CASSARANO S, et al. Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives[J].World J Gas,2020,26(5):456-465. [3] MOSSO E, BONETTO S, LONGOBARDI G, et al. Management of functional dyspepsia in 2020: a clinical point of view[J].Minerva Gas Dietol,2020,66(4):331-342. [4] STANGHELLINI V. Functional dyspepsia and irritable bowel syndrome: beyond rome Ⅳ[J].Dig Dis,2017,35(1):14-17. [5] 郑有花,白菊芳,杨玉霞,等. 奥替溴铵治疗功能性消化不良伴腹泻的临床研究[J].中国临床药理学杂志,2021,37(4):374. [6] 中国中西医结合学会消化系统疾病专业委员会. 功能性消化不良的中西医结合诊疗共识意见(2010)[J].中国中西医结合杂志,2011,31(11):1545-1549. [7] 王跃武. 伊托必利、多潘立酮和甲氧氯普胺联合治疗功能性消化不良的疗效与安全性分析[J].现代消化及介入诊疗,2017,22(2):215-218. [8] 孙小娟,贾林,王胜炳,等. 难治性功能性消化不良及其亚型患者的抑郁焦虑状况及其对生活质量影响的调查[J].现代消化及介入诊疗,2015,20(4):332-335. [9] SABBAGH P, JAVANIAN M, KOPPOLU V, et al. Helicobacter pylori infection in children: an overview of diagnostic methods[J].Eur J Clin Microbiol Infect Dis,2019,38(6):1035-1045. [10] MASUY I, VAN OUDENHOVE L, TACK J. Review article: treatment options for functional dyspepsia[J].Aliment Pharmacol Ther,2019,49(9):1134-1172. [11] 郑俊佳,黄彬,张竞超,等. 益生菌联合奥替溴铵治疗腹泻型肠易激综合征有效性与安全性的Meta分析[J].现代消化及介入诊疗,2021,26(1):25-31. [12] LOOR A, DUMITRASCU DL, SURDEA-BLAGA T, et al. Helicobacter pylori infection and positive Rome IV criteria for functional dyspepsia in Romanian medical students[J].J Med Life,2021,14(4):492-497. [13] 赵洁. 奥替溴铵联合益生菌治疗腹泻型肠易激综合征的临床疗效观察[J].现代消化及介入诊疗,2017,22(1):61-62. [14] 杨丽清,陈平湖,李嘉莉,等. 含盐酸小檗碱四联疗法对幽门螺杆菌阳性功能性消化不良的疗效评价[J].新医学,2019,50(6):453-456. [15] HAVA U, SRIVASTAVA A, MATHIAS A, et al. Functional dyspepsia in children: a study of pathophysiological factors[J].J Gas Hepatol,2021,36(3):680-686.
2025, Vol. 42 
